Interactive Health Communication for longer, better lives.

MM drug pricing- more possible advocacy issues

I posted about the possibility of possible advocacy on the part of b-m.org members yesterday. I have not yet read today's digest.

I came across this link just now- Awhile back a member mentioned designing an electronic petition of some kind- my thinking behind a member advocacy effort is that there are issues like drug priciing and healthcare policy that members may choose to discuss and possibly petition. I am tryiing to gauge interest before I try to program and research the issue.  David

Ottawa moves to reduce price of drug after cancer patients complain of gouging

From Thursday's Globe and Mail

A cancer drug will be subject to retroactive price controls after its cost to patients jumped almost ninefold – to as much as $4,200 a month.

The Patented Medicine Prices Review Board ruled that it has jurisdiction over the multiple myeloma drug thalidomide and can regulate its cost. 

http://www.theglobeandmai...

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
Please type in these five (5) letters or numbers to verify you aren't a SPAM Bot!
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.